香港股市 將在 1 小時 48 分鐘 開市

京東健康 (6618.HK)

HKSE - HKSE 延遲價格。貨幣為 HKD。
加入追蹤清單
23.250+0.150 (+0.65%)
收市:04:08PM HKT

京東健康

Jingdong Headquarters
Block C, Building 2 No. 20 Kechuang 11 Street, Daxing Dist. Yizhuang Eco. and Tech Development Zone
Beijing 101111
China

https://ir.jdhealth.com

版塊Healthcare
行業Medical Care Facilities
全職員工3,118

高階主管

名稱頭銜支付行使價出生年份
Mr. Enlin JinCEO & Executive Director2.07M1981
Ms. Deng HuiChief Financial Officer1987
Mr. Ming King Chiu FCIS, FCSCompany Secretary1977
截止 2022年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 HKD。

描述

JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People's Republic of China and internationally. It offers pharmaceutical and healthcare products, including OTC drugs, prescription drugs, and medical devices and supplies, as well as health supplements and tonics through direct selling and an online retail pharmacy network. The company also provides online medical consultation, consumer healthcare, and health management services; hospital or doctor referral, health check-ups, genetic testing, and beauty care services; and intelligent healthcare solutions, as well as technical and advertising services. In addition, it is involved in order management, client management, and other merchants operational and maintenance support activities. The company was incorporated in 2018 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. operates as a subsidiary of JD Jiankang Limited.

公司管治

截至 無 止,京東健康 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。